Log In
Print
BCIQ
Print
Print this Print this
 

ENMD-2076

  Manage Alerts
Collapse Summary General Information
Company CASI Pharmaceuticals Inc.
DescriptionInhibitor of aurora kinase A (AURKA; Aurora-A) and multiple tyrosine kinases
Molecular Target Aurora kinase A (AURKA) (Aurora-A) ; Vascular endothelial growth factor (VEGF) receptor 2 (VEGFR-2) (KDR/Flk-1)
Mechanism of ActionKinase inhibitor; Aurora kinase A inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today